Dihydroergotamine Mesylate Nasal 69097-0503-31
- Manufacturer
- Cipla Usa Inc.
- Dosage Form
- Spray, Metered
- Route
- Nasal
- Product Type
- Human Prescription Drug
- Marketing Start
- May 23, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA212907
Need to source Dihydroergotamine Mesylate Nasal? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dihydroergotamine Mesylate | 4 mg/mL |
Drug Class
Ergotamine Derivative [EPC]Ergotamines [CS]
Selected Package
69097-0503-31Selected1 VIAL in 1 KIT (69097-503-31) / 1 mL in 1 VIAL
Other packages for this product(1)
8 VIAL in 1 KIT (69097-503-27) / 1 mL in 1 VIAL